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HIT who have required valve replacement.
Bivalirudin’s half-life of 25 minutes, the
ability to monitor activated clotting time,
and the lack of cross-reactivity with hepa-
rin antibodies were advantages that con-
vinced my group to use it for these patients
with HIT. The patients did well, requiring
an average of 2 units of blood per patient.
My suspicion is that off-pump revascu-
larization with bivalirudin rather than dan-
aparoid would result in lower use of blood
products. It is likely that even on-pump
coronary artery bypass grafting with biva-
lirudin as the anticoagulant will result in
lower blood product use in the HIT cohort.
Frank A. Baciewicz, Jr, MD
Cardiothoracic Surgery
Wayne State University
School of Medicine
Detroit, MI 48201
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Reply to the Editor:
I thank Dr Baciewicz for his comments
regarding our article and thank you for the
opportunity to respond to him. We chose to
compare low dose of the anti-Xa inhibitor
danaparoid with standard heparin in off-
pump coronary artery bypass grafting be-
cause of our significant clinical experience
with the former drug. Although it is not
superior to standard heparin, low-dose dan-
aparoid offers a safe alternative for patients
undergoing off-pump coronary artery by-
pass grafting when heparin is contraindi-
cated.
My group and I have read with interest
the reports on bivalirudin, but we remain
concerned by the limited clinical data
available. In fact, we found only two re-
ports of cardiac surgical patients in the
literature, with one of the patients showing
a large blood drainage through the chest
tubes.1,2
Our current options for patients with
heparin-induced thrombocytopenia are to
use low-dose danaparoid and off-pump
coronary artery bypass grafting or to wait
for disappearance of the antiplatelet anti-
bodies and use a standard protocol of hep-
arin.
Michel Carrier, MD
Department of Surgery
Montreal Heart Institute
Research Center
Montreal, Quebec, Canada
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Apical versus basal partial
ventriculectomy
To the Editor:
With regard to the recent study of Koyama
and colleagues published in the Journal of
Thoracic and Cardiovascular Surgery,1
your readers should be aware that the au-
thors have done no more than confirm the
previous observations of Savage and col-
leagues,2 namely, that reducing volume by
constricting or resecting the apical half of
the ventricular cone has no significant ef-
fect on ventricular pump function. Their
findings also confirm extensive clinical
studies3-6 showing that reduction of the
radius of the ventricle in its upper two
thirds improves pump function, provided
that the ventricle had been markedly di-
lated prior to such an intervention. Thus,
simply by using a figure-of-eight symmet-
rical technique of resection, Konertz and
colleagues5 have achieved results that sur-
pass the current success of cardiac trans-
plantation.
Your readers should also note that the
technique used by the Japanese group to
induce cardiac failure1 produced minimal
alterations in left ventricular function.
Thus, having reduced the radius of the left
ventricle, the diameter in their experimen-
tal study was smaller than under control
conditions. As is well established, how-
ever, any persistent therapeutic effect of
reducing ventricular radius in the clinical
situation is dependent in the degree of pre-
existing ventricular dilation.3-6
Furthermore, due to the beta-blockade
used as part of the experimental setup, the
ensuing bradycardia will have prevented
their hearts from compensating adequately
for the confined stroke volume, as would
have occurred under physiological condi-
tions simply due to an increase in heart
rate. It is irrelevant, therefore, to measure
cardiac output under these experimental
conditions. At all events, stroke volume
increased by one quarter when the radius
was reduced along the basal two thirds of
the heart.
There are then several other problems
with the description and interpretation of
the Japanese group1 that need to be drawn
to the attention of your readers. It is incor-
rect to state that Batista advocated the api-
cal region of the left ventricle as a primary
area for resection. His primary intention
was simply to reduce the radius of the
dilated left ventricle. Furthermore, contrary
to the conclusion drawn by the authors,1
the experimental results show clearly that
plication of the apical segment produces no
positive therapeutic effect. Nor, contrary to
the assertions made by Torrent-Guasp and
his colleagues,7,8 does such plication have
any major detrimental impact on global
ventricular pump function. When consider-
ing the differences observed in left ventric-
ular function after apical or subbasal reduc-
tion of radius in this study, we need to
remember that it is the extensive circular
muscular layer enclosing the upper two
thirds of the left ventricular cone that is
largely responsible for left ventricular ejec-
tion. By reducing its radius, working con-
ditions for the left ventricle are improved,
thus ameliorating its pump function. This
positive effect, however, is mitigated by
plication of the interpapillary segment as
performed by the Japanese investigators, as
this procedure plicates also the marginal
arteries. As has been shown,9 the resulting
ischemic damage extends well beyond the
plicated segment. Indeed, such collateral
damage may well have been more signifi-
cant in those hearts that were plicated up to
the base in the Japanese study as compared
with those plicated only along the apical
half. The positive effect of reducing left
ventricular radius probably would have
been more pronounced had a less traumatic
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technique been used with the aim of pre-
serving the marginal arteries.
In summary, therefore, the authors have
done no more than confirm that resection or
constriction at the apex has a strictly cos-
metic effect on ejection fraction and a neg-
ligible effect on global left ventricular
function. There is no need to invoke any
pivotal impact of the spiraling muscles pre-
sumed to be involved in ventricular filling
so as to explain the lack of therapeutic
benefit. Indeed, the authors have provided
no evidence of a major impairment of the
dynamics of the ventricular filling apart
from a moderate increase in the filling pres-
sure of the left ventricle and a decrease by
one tenth in stroke volume. In our opinion,
this latter finding is more likely due to the
overcorrection of the volume of the ventri-
cle by reducing its long axis. They should
remember that clinical results have now
provided ample evidence that when the left
ventricle is dilated, resection of any part of
its walls, including the septum, is tolerated
without impairing left ventricular func-
tion.3-6 Indeed, a marked improvement in
left ventricular function is achieved when-
ever the radius of the upper two thirds of
the left ventricle is significantly reduced.
The conclusions drawn by the authors,
namely, that surgical intervention on the
left ventricular apex is markedly detrimen-
tal, are not, in our opinion, supported by
their experimental evidence.
P. P. Lunkenheimera
R. H. Andersonb
Klinik und Poliklinik fu¨r Thorax-, Herz- und
Gefa¨chirurgiea
University Mu¨nster
Mu¨nster, Germany
Cardiac Unit, Institute of Child Healthb
University College
London, United Kingdom
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Reply to the Editor:
Savage and colleagues’ study1 demon-
strated that volume reduction surgery
(VRS) in a model of left ventricular (LV)
aneurysm without global LV dysfunction
plicated only LV apex. On the other hand,
apex-sacrificing VRS in our series reduced
the diameter of not only LV apex but also
LV mid-portion in a model of global LV
dysfunction. The effects of volume reduc-
tion in akinetic or dyskinetic area are dif-
ferent from hypokinetic area.2 Drs Lunken-
heimer and Anderson support reduction of
the radius of the ventricle in its upper two
thirds (ie, basal). We agree with them on
that point, and reduction of the upper two
thirds of left ventricle is the same as our
apex-sparing VRS. In clinical series, how-
ever, no one has described or advocated
reduction of the radius of the ventricle in its
upper two thirds. The letter by Drs Lunken-
heimer and Anderson focused on the issue
in LV aneurysm or ischemic cardiomyop-
athy (raised by Savage and colleagues1),
but the disease that we studied via this
animal model was dilated cardiomyopathy
(ie, nonischemic). From this viewpoint,
their criticism is interesting and important
but misdirected.
Konertz and coworkers3 reported excel-
lent results of VRS but they also did not
described reduction of the upper two thirds
of left ventricle, and a majority of their
cases are ischemic cardiomyopathy. Again,
our study was focused on the dilated car-
diomyopathy (nonischemic cardiomyopa-
thy, a different disease). It is difficult to
adopt their results to our study.
Theoretically the therapeutic effect of
reducing ventricular radius is at least in
part dependent on the degree of preexisting
ventricular dilation. In the clinical setting,
however, operative mortality is high and
LV redilatation and dysfunction are not
rare after VRS.4-10 This suggests that the
theoretical concept is not necessarily repro-
ducible in the clinical situation and that the
way to excise and repair the LV is also
important. Although there are some limita-
tions due to the model of acute heart failure
induced by -blocker, the heart rate before
and after VRS was statistically no different
between the 2 groups. LV contractility in
apex-sparing VRS was shown to be supe-
rior to apex-sacrificing VRS, and LV end-
diastolic pressure was lower in apex-spar-
ing VRS. Those differences between the 2
groups were significant.
Batista’s group described an incision
made at the apex of the left ventricle. In our
article,2 we never stated that Batista and
colleagues advocated the apex resection,
but they did not try to preserve the apex as
much as possible. In fact, Lunkenheimer
and colleagues11 use the term “oyster-
shaped excision” in their case report, fol-
lowing the scheme of Batista’s operation
by widely resecting the LV apex. Through-
out our article we tried to show the poten-
tial pitfall of the great operation described
by Batista and colleagues and to improve
it. There would be some ischemic damage
extending beyond the plicated segment in
VRS, and we have described plication ef-
fects in the adjacent area in our study lim-
itation. It is unknown, however, whether
the ischemic damage follows according to
the position of resection or plication area.
However, this potential concern of com-
promising the marginal arteries is equally
applicable to conventional Batista proce-
dure. Further investigation would be war-
ranted.
We have already demonstrated these 2
types of VRS in a model of chronic dilated
cardiomyopathy.12 Elevation of LV end-
diastolic pressure and LV redilatation were
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